Robert Huddart💙
@robert_huddart
Followers
753
Following
1K
Media
31
Statuses
909
🚨BIG news 🚨 The ICR has received the Queen Elizabeth Prize for Higher Education for our groundbreaking radiotherapy research, celebrated at St James’ palace tonight. As a team, with @royalmarsdenNHS, we have improved cancer care worldwide through radiotherapy innovation
8
7
98
This seems like a natural evolution to me. In ten years will it be inconceivable that we use one radiotherapy plan for a whole course of treatment, based on a snapshot of anatomy weeks before? @royalmarsdenNHS Lots of work needed to make this accessible for all
Simulation-free radiotherapy on the MR-linac in prostate cancer https://t.co/Hr0Ep60RvC This study examined whether diagnostic MRI (dMRI) scans could replace dedicated simulation imaging for planning MRI-guided adaptive radiotherapy (MRIgART) in #ProstateCancer . Reviewing
0
6
36
Looking forward to the 20th MR-Linac consortium hosted in London this year. Use of adaptive radiotherapy is the next frontier, need lots of collaboration to continue delivering high quality clinical data+trials to test the benefits @Xristodouleas @Elekta
2
4
33
@oncology_bg @oncodaily @TheLancetOncol @SamuelXStevens @lateuwen Thanks. So much good stuff in there but here is one of the most important: crossover. If crossover contaminates OS then it simply tells you there is no OS value in bringing the drug earlier or combining with earlier line treatment - you could and should just use it sequentially.
0
3
7
Fabulous work @VedangMurthy . Really validates Egyptian study
Improved onc outcomes with post-op RT for bladder cancer BART trial by @TataMemorial @VedangMurthy
#ASTRO25 @ASTRO_org
0
2
7
Delighted to share our new review on HER2 and urothelial carcinoma - from biology to biomarkers and therapeutic perspectives - now out in @NatRevUrol! Huge thanks to all the co-authors for this outstanding collaboration 🙌 @MattGalsky @emanuele_crupi @Pederfizzo
@OncoAlert
4
26
66
Adaptive radiotherapy in #BladderCancer: Phase II results from the #RAIDERII trial. @robert_huddart @ICR_London joins @UroCancerMD @VUMCurology to discuss. Daily imaging & tailored plans for improved treatment precision for 98% of patients with low toxicity & promising disease
0
6
10
Want to work in the cutting edge Uro-oncology unit at the Royal Marsden? An opportunity to work with #alisontree, #chrisparker, #shaistahafeez, #juliamurray among others. We are looking for TWO clinical oncologists to join us. Link to application below
2
12
17
News for UK radiotherapy community. Pleased to say that thanks to @macmillancancer we have been able to establish #ctrad. We plan a proposals guidance meeting on 8.7.25 If you have a new trial idea, wish to attend please contact ctrad@macmillan.org to register. @RCRadiologists
4
9
27
Excited to share that our narrative review on the management of testicular cancer is now online at @JCOOP_ASCO Read here: https://t.co/9i5P1HAgCm
@DanieleRaggi83 @robert_huddart @ASCO @JCO_ASCO @TestesCancer @TesticularUK @TCSociety @CheckOneTwoPod
ascopubs.org
Testicular cancer is the most common malignancy in males age 15-40 years and one of the most curable cancers, with a cumulative 10-year survival rate exceeding 90%. Management strategies depend on...
1
7
11
Adaptive radiotherapy in #BladderCancer: Phase II results from the #RAIDERII trial. @robert_huddart @ICR_London joins @UroCancerMD @VUMCurology to discuss. Daily imaging & tailored plans for improved treatment precision for 98% of patients with low toxicity & promising disease
1
5
6
Great honor to be at #ESTRO25 to discuss the bladder sparing approach with medical tx alone in #MIBC. Challenging topic pending EV-P combo in EV304 study. Patient's selection remains critical. @robert_huddart @fontev1 @GiulioFrancoli1 @StAr_MCM74 @OncoAlert @WorldBladderCan
1
9
40
🎯 major takeaways from the brilliant presentation on bladder sparing treatment by @robert_huddart
#ESTRO2025
0
2
7
One of the best scientific debates I’ve witnessed between Prof Mike Seckl @ImperialNHS and Prof @robert_huddart @royalmarsdenNHS on management of brain mets in GCT patients. Thank you both for a superb session. #NGCGEaling25 @NGermCellG
0
5
20
Adaptive radiotherapy in #BladderCancer: Phase II results from the #RAIDERII trial. @robert_huddart @ICR_London joins @UroCancerMD @VUMCurology to discuss. Daily imaging & tailored plans for improved treatment precision for 98% of patients with low toxicity & promising disease
0
3
9
[3/3] Robert Huddart, Fay Cafferty and Alison Reid received a Clinical Trial Award to assess circulating serum microRNA as a #biomarker for relapse in Phase 2/3 trial to reduce the burden of standard active surveillance in stage I germ cell tumours. #CRUKFunded #tyacancer
0
4
7
#RAIDER trial: Safety of tumor-directed dose escalation. 💡 Adaptive radiotherapy reshapes bladder cancer care! Dr. @robert_huddart @ICR_London and @l_ballas discuss RAIDER trial findings: safe dose escalation, low toxicity, and preserved quality of life using tumor-directed
0
4
11
💫🌟🔬 Unraveling the Genetic Landscape of Testicular Germ Cell Tumors (TGCT)! 🧬🌟💫 ❗️Largest whole-exome meta-analysis in TGCT to date sheds light on genetic predisposition in 1,435 cases vs. 18,284 controls. #ZeidKuzbari @CRowlandsBio #IsaacWade #AliceGarrett
@LovedayChey
0
17
49